Immatics (IMTX) Revenue (2019 - 2025)

Immatics (IMTX) reported Revenue of $23.0 million for Q4 2025, down 61.73% on a YoY basis from $60.1 million in Q4 2024, and up 279.34% sequentially from $6.1 million in Q3 2025.

Immatics (IMTX) Revenue (2019 - 2025) Analysis & Trends

Immatics (IMTX) has 7 years of Revenue data on file, last reported at $23.0 million in Q4 2025.

  • For the quarter ending Q4 2025, Revenue fell 61.73% year-over-year to $23.0 million; the trailing twelve-month figure through Dec 2025 stood at $54.0 million (down 68.01% YoY), and the FY2025 full-year result was $54.5 million, down 67.67% from the prior year.
  • Revenue grew to $23.0 million in Q4 2025, from $6.1 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $115.5 million in Q1 2022 to a low of $5.4 million in Q2 2025.
  • A 5-year average of $25.5 million and a median of $18.2 million in 2021 frame the typical range for Revenue.
  • Across the five-year window, Revenue surged 1193.39% in 2022 and sank 90.9% in 2023, its largest moves.
  • Tracing IMTX's Revenue over 5 years: stood at $18.0 million in 2021, then surged by 113.49% to $38.4 million in 2022, then sank by 55.4% to $17.1 million in 2023, then soared by 250.91% to $60.1 million in 2024, then tumbled by 61.73% to $23.0 million in 2025.
  • Business Quant data shows IMTX's Revenue at $23.0 million in Q4 2025, $6.1 million in Q3 2025, and $5.4 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.51 Bn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 2.99 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 3.61 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.56 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Immatics 1.14 Bn 1.14 Bn - 23.00 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 23.00 Mn
Sep 30, 2025 6.06 Mn
Jun 30, 2025 5.36 Mn
Mar 31, 2025 19.55 Mn
Dec 31, 2024 60.11 Mn
Sep 30, 2024 55.52 Mn
Jun 30, 2024 20.20 Mn
Mar 31, 2024 32.88 Mn
Dec 31, 2023 17.13 Mn
Sep 30, 2023 6.45 Mn
Jun 30, 2023 24.34 Mn
Mar 31, 2023 10.51 Mn
Dec 31, 2022 38.41 Mn
Sep 30, 2022 15.18 Mn
Jun 30, 2022 18.37 Mn
Mar 31, 2022 115.50 Mn
Dec 31, 2021 17.99 Mn
Sep 30, 2021 7.60 Mn
Jun 30, 2021 6.25 Mn
Mar 31, 2021 8.93 Mn